Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon
arrow-right
Use Icons In The App

Try a synonym, or sign up to request an icon from the app.

Cardiomyocyte (concentric hypertrophy, binucleated)

Cardiomyocyte (concentric hypertrophy, binucleated) - Editable icon of a rectangular, concentric hypertrophiccardiomyocyte with banded sarcomere striations and two nuclei
[{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4a3d9070b76/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4a3d9070b76/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c43891070b74/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c43891070b74/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4163e070b73/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4163e070b73/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c44d1c070b72/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c44d1c070b72/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c427b5070b71/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c427b5070b71/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c44ce6070b70/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c44ce6070b70/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c419ef070b6f/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c419ef070b6f/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c40b68070b6e/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c40b68070b6e/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c435f2070b6d/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c435f2070b6d/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c45930070b6c/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c45930070b6c/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c44d0f070b6b/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c44d0f070b6b/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4ad33070b6a/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4ad33070b6a/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4ccc0070b69/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4ccc0070b69/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4feb7070b68/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4feb7070b68/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4387e070b67/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4387e070b67/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c40bee070b66/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c40bee070b66/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4b3e0070b65/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4b3e0070b65/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c42704070b64/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c42704070b64/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c44b58070b63/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c44b58070b63/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4b663070b62/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4b663070b62/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4236f070b61/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4236f070b61/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c44825070b60/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c44825070b60/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4457c070b5f/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4457c070b5f/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c426f6070b5e/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c426f6070b5e/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c47fc1070b5d/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c47fc1070b5d/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c47018070b5c/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c47018070b5c/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4775b070b5b/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4775b070b5b/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4dad1070b5a/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4dad1070b5a/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c483d4070b59/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c483d4070b59/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c45281070b58/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c45281070b58/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4686b070b57/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4686b070b57/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c41e27070b56/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c41e27070b56/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c451a7070b55/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c451a7070b55/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4109c070b54/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4109c070b54/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c427e7070b53/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c427e7070b53/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c457ec070b52/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c457ec070b52/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c48d2a070b51/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c48d2a070b51/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4746c070b50/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4746c070b50/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c47a80070b4f/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c47a80070b4f/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c47ab3070b4e/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c47ab3070b4e/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c478ca070b4d/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c478ca070b4d/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c48576070b4c/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c48576070b4c/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c484fb070b4b/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c484fb070b4b/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c40e0e070b4a/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c40e0e070b4a/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c46b91070b49/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c46b91070b49/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4c06b070b48/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4c06b070b48/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4a8ff070b47/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4a8ff070b47/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4690c070b46/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4690c070b46/6529532f32b65c6e3f1be567.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6529666f7fa8c4a32e070b45/6529532f32b65c6e3f1be567.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6529666f7fa8c4a32e070b45/6529532f32b65c6e3f1be567.png"}]
Keywords
cardiomyocyte,hypertrophy,hypertrophic,concentric hypertrophy,hypertrophic cardiomyopathy,HCM,pathological hypertrophy,heart damage,heart failure,ventricular hypertrophy,cardiac stress,hypertension,myocardial infarction,pathology,illness,heart,cardiac,cardio,smooth muscle,cardiac muscle,cardiac muscle cell,heart muscle,cardiac tissue,myocardium,involuntary,striated,intercalated disc,sarcomere,actin,myosin,troponin,t-tubule,myofibril,myofilament,cytoplasm,nucleus,cell membrane,contract,contraction,contractile,cardiomyopathy,heartbeat,heart contraction,heart rhythm,cardiac cycle,functional syncytium,action potential,excitation-contraction coupling,rectangular,healthy,isolated,lab research,in vitro,mammalian,adult,human,rodent,mouse,rat,cardiovascular system,cardiovascular,circulatory system,cardiovascular physiology,cardiology,regenerative medicine,tissue engineering,binucleated,two nuclei,cultured cardiomyocyte,cultured,cardiomyocyte
Image types

Cardiomyocyte (concentric hypertrophy, binucleated) icon JPEG

Cardiomyocyte (concentric hypertrophy, binucleated) icon PNG

Cardiomyocyte (concentric hypertrophy, binucleated) icon SVG

Cardiomyocyte (concentric hypertrophy, binucleated) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cardiomyocyte (concentric hypertrophy, binucleated) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the Cardiomyocyte (concentric hypertrophy, binucleated) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the Cardiomyocyte (concentric hypertrophy, binucleated) icon customizable in BioRender?
Most icons in BioRender, including the Cardiomyocyte (concentric hypertrophy, binucleated) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the Cardiomyocyte (concentric hypertrophy, binucleated) icon in their work?
BioRender users often use the Cardiomyocyte (concentric hypertrophy, binucleated) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.
Can I export figures that include the Cardiomyocyte (concentric hypertrophy, binucleated) icon for publication or presentations?
Yes, figures containing the Cardiomyocyte (concentric hypertrophy, binucleated) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the Cardiomyocyte (concentric hypertrophy, binucleated) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the Cardiomyocyte (concentric hypertrophy, binucleated) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now